FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15546011000001108: Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
54958401000001111 Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
54958501000001110 Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Is a Irinotecan 300mg/15ml solution for infusion vials true Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Is a Campto true Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Has specific active ingredient Irinotecan hydrochloride trihydrate false Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Has active ingredient Irinotecan true Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Has specific active ingredient Irinotecan hydrochloride trihydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) 1 vial Has AMP True Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start